Rapamycin's effect on vasomotion in the rat.
Milliard
S
S
Laboratory of Experimental Surgery, Notre-Dame Hospital, University of Montreal, Quebec, Canada.
Silva
A
A
Blaise
G
G
Chen
H
H
Xu
D
D
Qi
S
S
Daloze
P
P
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / Q000494:pharmacology; D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001012:Aorta, Abdominal / Q000187:drug effects / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D009126:Muscle Relaxation / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D010656:Phenylephrine / Q000494:pharmacology; D011090:Polyenes / Q000494:pharmacology*; D011092:Polyethylene Glycols / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D020123:Sirolimus; D014661:Vasoconstriction / Q000187:drug effects
D007166:Immunosuppressive Agents; D011090:Polyenes; D010656:Phenylephrine; D011092:Polyethylene Glycols; D011189:Potassium Chloride; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000109:Acetylcholine; D020123:Sirolimus